This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations by Dominique Verhelle
Introduction
Dominique Verhelle is an accomplished inventor based in Boston, MA. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative work focuses on combination therapies that enhance the effectiveness of existing treatments.
Latest Patents
Dominique holds a patent for his invention titled "EZH2 inhibitor combination therapies." This invention relates to combination therapies comprising an EZH2 inhibitor and a chemotherapeutic agent, along with associated pharmaceutical compositions, methods of treatment, and pharmaceutical uses. He has 1 patent to his name.
Career Highlights
Dominique Verhelle is currently employed at Pfizer Corporation, a leading global biopharmaceutical company. His role involves research and development aimed at improving therapeutic options for patients. His work is pivotal in advancing treatment methodologies in oncology.
Collaborations
Dominique collaborates with notable colleagues, including Manfred Kraus and Pei-Pei Kung, who contribute to his research efforts and enhance the scope of his projects.
Conclusion
Dominique Verhelle's innovative contributions to cancer treatment through his patent on EZH2 inhibitor combination therapies exemplify the impact of dedicated research in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile